COM701
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for COM701, covering 2024-07-18 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer [Phase 1, Phase 2]